文献速递心脏核医学

D-SPECT心肌灌注显像在INOCA与梗阻性CAD患者中的预后价值

Prognostic value of myocardial perfusion imaging with D-SPECT camera in patients with ischemia and no obstructive coronary artery disease (INOCA).
PubMed 文献 · J Nucl Cardiol · 2020-09-30

本研究纳入506例疑似CAD且未行血运重建、3个月内完成D-SPECT MPI与有创造影的患者,其中INOCA 232例(45.8%)。INOCA患者中33.2% D-SPECT MPI异常,梗阻性CAD患者中77.7%异常;两组异常者MACE率更高、无MACE生存率更低。INOCA合并D-SPECT异常者预后与梗阻性CAD患者相似,风险校正HR分别为2.55与2.06。

要点

  • INOCA患者中约三分之一D-SPECT MPI异常,提示存在可检测的缺血负担。
  • D-SPECT MPI异常与INOCA及梗阻性CAD患者MACE风险升高均独立相关。
  • INOCA合并D-SPECT异常者预后与梗阻性CAD患者相近,需加强风险管理。

核心结论

  • D-SPECT MPI可提供良好的预后信息,MPI异常者预后更差。
  • INOCA患者若D-SPECT MPI异常,其预后与梗阻性CAD患者相似。

研究设计与样本

  • 回顾性纳入连续疑似CAD且无既往CAD、3个月内完成D-SPECT MPI与有创造影的患者506例。
  • INOCA定义为冠状动脉狭窄<50%,梗阻性CAD定义为狭窄≥50%。
  • 随访主要不良心脏事件(MACE:心血管死亡、非致死性心肌梗死、血运重建、卒中、心力衰竭及心绞痛相关再住院)。

主要发现

  • 506例中INOCA 232例(45.8%),梗阻性CAD为其余患者。
  • INOCA患者中33.2% D-SPECT MPI异常,梗阻性CAD患者中77.7%异常。
  • 两组中D-SPECT MPI异常者MACE率更高、无MACE生存率更低。
  • INOCA合并D-SPECT MPI异常者的预后与梗阻性CAD患者相似。
  • Cox回归显示D-SPECT MPI异常的风险校正HR在INOCA为2.55 [1.11-5.87],在梗阻性CAD为2.06 [1.03-4.10]。

关键数值与推荐

  • INOCA:冠状动脉狭窄<50%;梗阻性CAD:冠状动脉狭窄≥50%。
  • D-SPECT MPI异常的风险校正HR:INOCA 2.55 [1.11-5.87],梗阻性CAD 2.06 [1.03-4.10]。

临床怎么用

  • 对INOCA患者可行D-SPECT MPI评估缺血负担,MPI异常者应按高危人群管理。
  • D-SPECT MPI异常可作为INOCA与梗阻性CAD患者MACE风险分层的依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Myocardial perfusion imaging (MPI) with a novel D-SPECT camera maintains excellent prognostic value compared to conventional SPECT. However, information about the relationship between D-SPECT MPI and the prognosis in patients with ischemia and no obstructive coronary artery disease (INOCA) is limited. The objective of this study was to evaluate the prognostic value of MPI with D-SPECT in INOCA and obstructive coronary artery disease (CAD) patients. METHODS: All consecutive patients with suspected CAD and without prior CAD who underwent D-SPECT MPI and invasive coronary angiography within 3 months were considered. INOCA and obstructive CAD were defined as < 50% and ≥ 50% coronary stenosis, respectively. Patients were followed-up for the occurrence of major adverse cardiac events (MACE: cardiovascular death, nonfatal myocardial infarction, revascularization, stroke, heart failure and angina-related rehospitalization). RESULTS: Among 506 patients, 232 (45.8%) were INOCA patients. A total of 33.2% of the INOCA patients had abnormal D-SPECT MPI, whereas 77.7% of the obstructive CAD patients had abnormal D-SPECT MPI. In both groups, patients with abnormal D-SPECT MPI demonstrated higher MACE rates and lower survival free of MACE. In addition, patients with INOCA and abnormal D-SPECT MPI had a poor prognosis similar to that of the obstructive CAD patients. Cox regression analysis showed that the risk-adjusted hazard ratios for abnormal D-SPECT MPI were 2.55 [1.11-5.87] and 2.06 [1.03-4.10] in the INOCA and obstructive CAD patients, respectively. CONCLUSIONS: D-SPECT MPI provides excellent prognostic information, with a more severe prognosis in patients with abnormal D-SPECT MPI. INOCA patients with abnormal D-SPECT MPI experience a poor prognosis similar to that of patients with obstructive CAD.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Liu L, Abdu FA, Yin G, et al. Prognostic value of myocardial perfusion imaging with D-SPECT camera in patients with ischemia and no obstructive coronary artery disease (INOCA). J Nucl Cardiol. 2020. PMID: 33000403. doi:10.1007/s12350-020-02252-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。